Healthy volunteers needed to test new high blood pressure drug combo
NCT ID NCT07312799
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This early-stage study will test two experimental drugs, AD-2321 and AD-2322, in 41 healthy adults aged 19 to 64. The goal is to see how the drugs interact in the body and whether they are safe. Participants will take both drugs in a set order, and researchers will measure drug levels in the blood. No direct treatment benefit is expected, but the results will guide future studies for people with high blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H+ Yangji Hospital
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.